Accordingly, we performed flow cytometry analysis on subsets of CD4+ and CD8+T-cells, B-cells, monocytes and dendritic cells, selected on the basis of previous progressive MS pathology and immunology studies, and subsequently related frequencies of significantly enriched subsets to disease activity. The gene discussed is CD4; the disease is myeloid sarcoma.